Doctor profile · Federal record
Dr. Bozena Witek, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Chicago, IL
- NPI 1275639585
- Accepts Medicare
- MIPS 66.3 / 100 · 2023
- 43 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
7447 W Talcott Ave, Suite One
Chicago, IL 606313745
(773) 774-0042
fax (773) 774-2008
Credentials & registration
- NPI registered
- September 2006 — 20 yrs on file
- Profile last updated
- December 17, 2021
- Year of graduation
- 1983 — 43 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Illinois #036076914
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1275639585. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
49,075
Distinct HCPCS
10
Medicare allowed
$1,420,621
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9271 |
Injection, pembrolizumab, 1 mg | 16,800 | 14 | $54 | |
J1453 |
Injection, fosaprepitant, 1 mg | 16,500 | 24 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 5,100 | 16 | $23 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,490 | 39 | $0 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 1,342 | 22 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 1,290 | 30 | $1 | |
J0640 |
Injection, leucovorin calcium, per 50 mg | 1,203 | 11 | $4 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 782 | 204 | $133 | |
J9190 |
Injection, fluorouracil, 500 mg | 781 | 11 | $2 | |
Q5122 |
Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg | 768 | 23 | $116 |
In context: peer comparison
Among 77 peers in this city , average services per provider: 870. This provider delivers 56× the peer median.Open Payments
Industry payments received
All-time total
$2,805
Transactions
102
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 30 | $483.38 | |
| PFIZER INC. | 12 | $246.15 | |
| Celgene Corporation | 6 | $177.15 | |
| AstraZeneca Pharmaceuticals LP | 7 | $148.75 | |
| E.R. Squibb & Sons, L.L.C. | 7 | $134.16 | |
| Merck Sharp & Dohme LLC | 5 | $130.68 | |
| Astellas Pharma US Inc | 5 | $117.74 | |
| ABBVIE INC. | 5 | $117.48 | |
| Gilead Sciences, Inc. | 5 | $110.93 | |
| Eisai Inc. | 4 | $106.74 | |
| Daiichi Sankyo Inc. | 4 | $93.51 | |
| Amneal Pharmaceuticals LLC | 4 | $87.31 | |
| GlaxoSmithKline, LLC. | 3 | $79.92 | |
| Incyte Corporation | 3 | $71.87 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $57.74 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
904
Patients
231
Total drug cost
$1,813,414
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 185 | 38 | $5,317 |
| Gabapentin | Generic | 121 | 29 | $2,062 |
| Eliquis (Apixaban) | Brand | 66 | 14 | $47,539 |
| Revlimid (Lenalidomide) | Brand | 51 | 0 | $998,206 |
| Alendronate Sodium | Generic | 49 | 0 | $576 |
| Anastrozole | Generic | 49 | 14 | $2,878 |
| Ondansetron Odt (Ondansetron) | Brand | 49 | 28 | $1,314 |
| Pantoprazole Sodium | Generic | 49 | 20 | $502 |
| Hydroxyurea | Generic | 48 | 13 | $2,262 |
| Ibrance (Palbociclib) | Brand | 44 | 0 | $747,820 |
Hospital affiliations
Frequently asked questions
What is Dr. Bozena Witek's medical specialty?
Dr. Bozena Witek practices Hematology & Oncology Physician in Chicago, IL.
Where does Dr. Bozena Witek practice?
Dr. Bozena Witek practices at 7447 W Talcott Ave, Chicago, IL 606313745. Office phone: 7737740042.
What is Dr. Bozena Witek's NPI?
Dr. Bozena Witek's National Provider Identifier (NPI) is 1275639585, issued by NPPES.
Does Dr. Bozena Witek accept Medicare assignment?
Yes. Dr. Bozena Witek accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Bozena Witek commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.